Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study
about
Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study
description
scientific article published on 12 July 2019
@en
name
Tumor mutation burden and circ ...... a prospective biomarker study
@en
type
label
Tumor mutation burden and circ ...... a prospective biomarker study
@en
prefLabel
Tumor mutation burden and circ ...... a prospective biomarker study
@en
P2093
P50
P1476
Tumor mutation burden and circ ...... a prospective biomarker study
@en
P2093
Bernhard Klumpp
Dennis Döcker
Dirk Hadaschik
Florian Battke
Maria Kopp
Martin Schulze
Maximilian Frick
Nicola Tietze
Peter Martus
Saskia Biskup
P356
10.1186/S40425-019-0659-0
P577
2019-07-12T00:00:00Z